Publication | Closed Access

Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus genotype 5 or 6 infection (ENDURANCE-5,6): an open-label, multicentre, phase 3b trial

Viral PersistenceHepatologyHepatitis CViral HepatitisAntiviral TherapyHepatitisVirologyChronic Viral InfectionAntiviral DrugMedicinePhase 3B